跳至主要内容
临床试验/IRCT201203018954N1
IRCT201203018954N1已完成未知

Aspirin for prevention of adverse pregnancy outcome in women with elevated alfa-feto protein in second trimester screening,a randomised clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 109 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
109

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • Inclusin criteria:16-20 gestational weeks pregnant women who attend Imam khomeini hospital clinic of perinatology,and have a second trimester AFP>2.5 MOM.They are divided into 2 groups with or without aspirin.
  • Patients are included in study who deliver in Imam khomeini hospital.
  • Exclusion criteria :maternal medical disease and uterus anomalies

排除标准

  • 未提供

研究者

相似试验

Aspirin for prevention of adverse pregnancy outcome... | 临床试验